FLUCELVAX quadrivalent (ccIIV4) a phase III randomized controlled trial : immunogenicity & safety results in young children (6 through 47 months of age)

Sylvester, Gregg C.

i

FLUCELVAX quadrivalent (ccIIV4) a phase III randomized controlled trial : immunogenicity & safety results in young children (6 through 47 months of age)

Public Domain

06/24/2021
By Sylvester, Gregg C.
Series: ACIP: Influenza

File Language:

English

Details

Personal Author:

Sylvester, Gregg C.
Corporate Authors:

Seqirus
Description:

02-influenza-sylvester-508.pdf
Subjects:

Influenza Vaccines
Series:

ACIP: Influenza
Document Type:

Still Image
Name as Subject:

ACIP meeting: 2021 Jun 24 ; ACIP meeting: 2021 Jun 24
Genre:

Presentation ; Conference Publications
Volume:

202108
Issue:

200202
Collection(s):

Advisory Committee on Immunization Practices (ACIP)
Main Document Checksum:

urn:sha-512:d372234eee7518a4dffcf4ba150993375531da9bccd7bc7062b06a53c80ce0ac20727db43612f8633af0d84184ebbb4c71df2f37392b1524941b83e15c2bab0b
Download URL:

https://stacks.cdc.gov/view/cdc/109098/cdc_109098_DS1.pdf
File Type:

[PDF - 445.44 KB ]

File Language:

English

ON THIS PAGE

Details Related Documents

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.